Table 6.

Table showing comparisons of parameters between the sarcopenic and non-sarcopenic diabetics.

Parameter	Sarcopenia	No Sarcopenia	p-Value
Total number	35 (22%)	124 (78%)
Male:female	18:17	64:60	0.985
Mean age	61 (±6.27)	56.38 (±5.59)	<0.001
Duration of diabetes	10 (±7.49)	7.69 (5.26)	0.037
Alcohol	2 (5.7%)	32 (25.8%)	0.010
Smoking	3 (8.6%)	27 (21.8%)	0.018
BMI	24.95 (±3.02)	28.09 (±3.21)	<0.001
Waist circumference	91.54 (±10.05)	100.05 (±11.40)	<0.001
Physical activity	2 (5.7%)	71 (57.3%)	<0.001
Dyslipidemia	19 (54.28%)	78 (62.9%)	0.356
Statin	20 (57.14%)	58 (46.77%)	0.279
Hypertension	26 (74.3%)	55 (44.4%)	0.002
Insulin	16 (45.7%)	27 (21.8%)	0.005
Metformin	29 (82.9%)	114 (91.9%)	0.115
Sulphonylureas	11 (31.4%)	70 (56.5%)	0.009
DPP4 inhibitors	22 (62.9%)	82 (66.1%)	0.719
SGLT-2 inhibitors	12 (34.3%)	25 (20.2%)	0.081
Alpha glucosidase inhibitors	6 (17.1%)	35 (28.2%)	0.186
Combination of antidiabetics	32 (91.4%)	117 (94.35%)	0.873
AMI	5.81 (±0.80)	7.37 (±1.04)	<0.001
HGS	21.84 (±6.19)	30.06 (±8.09)	<0.001
GS	0.84 (±0.12)	1.05 (±0.13)	<0.001
Neuropathy	22 (62.9%)	36 (29.0%)	<0.001
Nephropathy	17 (48.6%)	24 (19.4%)	<0.001
Retinopathy	14 (40.0%)	19 (15.3%)	0.001
FPG	148.68 (±53.70)	138.04 (±45.94)	0.246
PPG	215.31(±77.82)	214.81 (±63.108)	0.969
HbA1c	8.169 (±1.87)	8.467 (±1.92)	0.423
Fasting insulin	13.41 (±10.53)	13.98 (±11.48)	0.793
HOMA IR	4.90 (±4.57)	4.86 (±4.88)	0.287
Total cholesterol	166.22 (±47.98)	179.54 (±48.07)	0.150
Triglyceride	130.85 (±48.18)	175.64 (±119.86)	0.032
HDL	49.45 (±15.29)	44.56 (±13.07)	0.062
LDL	91.82 (±39.4)	100.35 (±37.503)	0.244
VLDL	25.00 (±8.82)	32.70 (±18.16)	0.017
Serum albumin	4.15 (±0.628)	4.23 (±0.48)	0.392
ALP	89.11 (±30.00)	90.17 (±30.12)	0.854
eGFR	71.51 (±14.84)	86.35 (±18.16)	<0.001
Urine ACR	0.40 (±0.43)	0.17 (±0.27)	<0.001
Serum calcium	9.35 (±0.55)	9.60 (±0.51)	0.011
Serum phosphorous	3.76 (±0.67)	3.62 (±0.64)	0.276
Serum 25-OH-vit D	24.45 (±9.48)	25.06 (±10.99)	0.766
Serum iPTH	32.24 (±17.45)	25.87 (±10.54)	0.008
TSH	2.43 (±0.86)	2.58 (±1.105)	0.454